|
[1]
|
Stein, C.J. and Colditz, G.A. (2004) Modifiable Risk Factors for Cancer. British Journal of Cancer, 90, 299-303.
http://dx.doi.org/10.1038/sj.bjc.6601509
|
|
[2]
|
Hanahan, D. and Weinberg, R.A. (2000) The Hallmarks of Cancer. Cell, 100, 57-70.
http://dx.doi.org/10.1016/S0092-8674(00)81683-9
|
|
[3]
|
Grothey, A. and Schmoll, H.J. (2001) New Chemotherapy Approaches in Colorectal Cancer. Current Opinion in Oncology, 13, 275-286. http://dx.doi.org/10.1097/00001622-200107000-00011
|
|
[4]
|
Fidler, I.J. (2003) The Pathogenesis of Cancer Metastasis: The “Seed and Soil” Hypothesis Revisited. Nature Reviews Cancer, 3, 453-458. http://dx.doi.org/10.1038/nrc1098
|
|
[5]
|
Kalluri, R. (2009) EMT: When Epithelial Cells Decide to Become Mesenchymal-Like Cells. The Journal of Clinical Investigation, 119, 1417-1419. http://dx.doi.org/10.1172/JCI39675
|
|
[6]
|
Thiery, J.P., Acloque, H., Huang, R.Y. and Nieto, M.A. (2009) Epithelial-Mesenchymal Transitions in Development and Disease. Cell, 139, 871-890. http://dx.doi.org/10.1016/j.cell.2009.11.007
|
|
[7]
|
Thiery, J.P. and Sleeman, J.P. (2006) Complex Networks Orchestrate Epithelial-Mesenchymal Transitions. Nature Reviews Molecular Cell Biology, 7, 131-142. http://dx.doi.org/10.1038/nrm1835
|
|
[8]
|
Yang, J. and Weinberg, R.A. (2008) Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis. Developmental Cell, 14, 818-829. http://dx.doi.org/10.1016/j.devcel.2008.05.009
|
|
[9]
|
Stahel, R., Bogaerts, J., Ciardiello, F., et al. (2014) Optimising Translational Oncology in Clinical Practice: Strategies to Accelerate Progress in Drug Development. Cancer Treatment Reviews, 41, 129-135.
|
|
[10]
|
Garzon, R., Fabbri, M., Cimmino, A., et al. (2006) MicroRNA Expression and Function in Cancer. Trends in Molecular Medicine, 12, 580-587. http://dx.doi.org/10.1016/j.molmed.2006.10.006
|
|
[11]
|
DeSano, J.T. and Xu, L. (2009) A Regulation of Cancer Stem Cells and Therapeutic Implications. The AAPS Journal, 11, 682-692. http://dx.doi.org/10.1208/s12248-009-9147-7
|
|
[12]
|
Perera, R.J. and Ray, A. (2007) MicroRNAs in the Search for Understanding Human Diseases. BioDrugs, 21, 97-104.
http://dx.doi.org/10.2165/00063030-200721020-00004
|
|
[13]
|
He, L., He, X., Lim, L.P., et al. (2007) A msicroRNA Component of the p53 Tumour Suppressor Network. Nature, 447, 1130-1134. http://dx.doi.org/10.1038/nature05939
|
|
[14]
|
Davis, B.N. and Hata, A. (2009) Regulation of MicroRNA Biogenesis: A miRiad of Mechanisms. Cell Communication & Signal, 7, 18. http://dx.doi.org/10.1186/1478-811X-7-18
|
|
[15]
|
Davis, B.N., Hilyard, A.C., Nguyen, P.H., et al. (2009) Induction of Microrna-221 by Platelet-Derived Growth Factor Signaling Is Critical for Modulation of Vascular Smooth Muscle Phenotype. The Journal of Biological Chemistry, 284, 3728-3738. http://dx.doi.org/10.1074/jbc.M808788200
|
|
[16]
|
Shao, M., Rossi, S., Chelladurai, B., et al. (2011) PDGF Induced microRNA Alterations in Cancer Cells. Nucleic Acids Research, 39, 4035-4047. http://dx.doi.org/10.1093/nar/gkq1305
|
|
[17]
|
Butz, H., Racz, K., Hunyady, L. and Patocs, A. (2012) Crosstalk between TGF-β Signaling and the MicroRNA Machinery. Trends in Pharmacological Sciences, 33, 382-393.
http://dx.doi.org/10.1016/j.tips.2012.04.003
|
|
[18]
|
Bui, T.V. and Mendell, J.T. (2010) Myc: Maestro of MicroRNAs. Genes & Cancer, 1, 568-575.
http://dx.doi.org/10.1177/1947601910377491
|
|
[19]
|
Chang, T.C., Yu, D., Lee, Y.S., et al. (2008) Widespread microRNA Repression by Myc Contributes to Tumorigenesis. Nature Genetics, 40, 43-50. http://dx.doi.org/10.1038/ng.2007.30
|
|
[20]
|
He, L., Thomson, J.M., Hemann, M.T., et al. (2005) A microRNA Polycistron as a Potential Human Oncogene. Nature, 435, 828-833. http://dx.doi.org/10.1038/nature03552
|
|
[21]
|
Yu, G., Tang, J.Q., Tian, M.L., et al. (2012) Prognostic Values of the miR-17-92 Cluster and Its Paralogs in Colon Cancer. Journal of Surgical Oncology, 106, 232-237. http://dx.doi.org/10.1002/jso.22138
|
|
[22]
|
Dews, M., Homayouni, A., Yu, D., et al. (2006) Augmentation of Tumor Angiogenesis by a Myc-Activated MicroRNA Cluster. Nature Genetics, 38, 1060-1065. http://dx.doi.org/10.1038/ng1855
|
|
[23]
|
Ma, L., Young, J., Prabhala, H., et al. (2010) miR-9, a MYC/MYCN-Activated microRNA, Regulates E-Cadherin and Cancer Metastasis. Nature Cell Biology, 12, 247-256.
|
|
[24]
|
Klein, U., Lia, M., Crespo, M., et al. (2010) The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia. Cancer Cell, 17, 28-40.
http://dx.doi.org/10.1016/j.ccr.2009.11.019
|
|
[25]
|
Linsley, P.S., Schelter, J., Burchard, J., et al. (2007) Transcripts Targeted by The MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression. Molecular and Cellular Biology, 27, 2240-2252.
http://dx.doi.org/10.1128/MCB.02005-06
|
|
[26]
|
Bandres, E., Agirre, X., Bitarte, N., et al. (2009) Epigenetic Regulation of microRNA Expression in Colorectal Cancer. International Journal of Cancer, 125, 2737-2743. http://dx.doi.org/10.1002/ijc.24638
|
|
[27]
|
Toyota, M., Suzuki, H., Sasaki, Y., et al. (2008) Epigenetic Silencing of MicroRNA-34b/c and B-Cell Translocation Gene 4 Is Associated With CpG Island Methylation in Colorectal Cancer. Cancer Research, 68, 4123-4132.
http://dx.doi.org/10.1158/0008-5472.CAN-08-0325
|
|
[28]
|
Vogt, M., Munding, J., Gruner, M., et al. (2011) Frequent Concomitant Inactivation of miR-34a and miR-34b/c by CpG Methylation in Colorectal, Pancreatic, Mammary, Ovarian, Urothelial, and Renal Cell Carcinomas and Soft Tissue Sarcomas. Virchows Archive, 458, 313-322.
http://dx.doi.org/10.1007/s00428-010-1030-5
|
|
[29]
|
Goel, A. and Boland, C.R. (2012) Epigenetics of Colorectal Cancer. Gastroenterology, 143, 1442-1460.
|
|
[30]
|
Chang, S., Wang, R.H., Akagi, K., et al. (2011) Tumor Suppressor BRCA1 Epigenetically Controls Oncogenic MicroRNA-155. Nature Medicine, 17, 1275-1282. http://dx.doi.org/10.1038/nm.2459
|
|
[31]
|
Du Rieu, M.C., Torrisani, J., Selves, J., et al. (2010) MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions. Clinical Chemistry, 56, 603-612.
http://dx.doi.org/10.1373/clinchem.2009.137364
|
|
[32]
|
Munding, J.B., Adai, A.T., Maghnouj, A., et al. (2012) Global microRNA Expression Profiling of Microdissected Tissues Identifies miR-135b as a Novel Biomarker for Pancreatic Ductal Adenocarcinoma. International Journal of Cancer, 131, 86-95. http://dx.doi.org/10.1002/ijc.26466
|
|
[33]
|
Georgantas, R.W., Streicher, K., Greenberg, S.A., et al. (2014) Inhibition of Myogenic MicroRNAs 1, 133, and 206 by Inflammatory Cytokines Links Inflammation and Muscle Degeneration in Adult Inflammatory Myopathies. Arthritis & Rheumatology, 66, 1022-1033. http://dx.doi.org/10.1002/art.38292
|
|
[34]
|
Keklikoglou, I., Hosaka, K., Bender, C., et al. (2014) MicroRNA-206 Functions as a Pleiotropic Modulator of Cell Proliferation, Invasion and Lymphangiogenesis in Pancreatic Adenocarcinoma by Targeting ANXA2 and KRAS Genes. Oncogene, in press. http://dx.doi.org/10.1038/onc.2014.408
|
|
[35]
|
Poliseno, L., Tuccoli, A., Mariani, L., et al. (2006) MicroRNAs Modulate the Angiogenic Properties of HUVECs. Blood, 108, 3068-3071. http://dx.doi.org/10.1182/blood-2006-01-012369
|
|
[36]
|
Bonauer, A., Carmona, G., Iwasaki, M., et al. (2009) MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice. Science, 324, 1710-1713.
http://dx.doi.org/10.1126/science.1174381
|
|
[37]
|
Bierie, B. and Moses, H.L. (2006) Tumour Microenvironment: TGFbeta: The Molecular Jekyll and Hyde of Cancer. Nature Reviews Cancer, 6, 506-520. http://dx.doi.org/10.1038/nrc1926
|
|
[38]
|
Bockhorn, M., Jain, R.K. and Munn, L.L. (2007) Active versus Passive Mechanisms in Metastasis: Do Cancer Cells Crawl into Vessels, or Are They Pushed? The Lancet Oncology, 8, 444-448.
http://dx.doi.org/10.1016/S1470-2045(07)70140-7
|
|
[39]
|
Favaro, E., Lord, S., Harris, A.L. and Buffa, F.M. (2011) Gene Expression and Hypoxia in Breast Cancer. Genome Medicine, 3, 55. http://dx.doi.org/10.1186/gm271
|
|
[40]
|
Denko, N.C. (2008) Hypoxia, HIF1 and Glucose Metabolism in the Solid Tumour. Nature Reviews Cancer, 8, 705-713.
http://dx.doi.org/10.1038/nrc2468
|
|
[41]
|
Kulshreshtha, R., Ferracin, M., Negrini, M., et al. (2007) Regulation of MicroRNA Expression: The Hypoxic Component. Cell Cycle, 6, 1425-1430. http://dx.doi.org/10.4161/cc.6.12.4410
|
|
[42]
|
Kulshreshtha, R., Ferracin, M., Wojcik, S.E., et al. (2007) A MicroRNA Signature of Hypoxia. Molecular and Cellular Biology, 27, 1859-1867. http://dx.doi.org/10.1128/MCB.01395-06
|
|
[43]
|
Liu, L.Z., Li, C., Chen, Q., et al. (2011) miR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression. PLoS ONE, 6, e19139. http://dx.doi.org/10.1371/journal.pone.0019139
|
|
[44]
|
Nie, Y., Han, B.M., Liu, X.B., et al. (2011) Identification of MicroRNAs Involved in Hypoxia- and Serum Deprivation-Induced Apoptosis in Mesenchymal Stem Cells. International Journal of Biological Sciences, 7, 762-768.
http://dx.doi.org/10.7150/ijbs.7.762
|
|
[45]
|
Kong, D., Banerjee, S., Ahmad, A., et al. (2010) Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells. PLoS ONE, 5, e12445.
http://dx.doi.org/10.1371/journal.pone.0012445
|
|
[46]
|
Chang, C.J., Hsu, C.C., Chang, C.H., et al. (2011) Let-7d Functions as Novel Regulator of Epithelial-Mesenchymal Transition and Chemoresistant Property in Oral Cancer. Oncology Reports, 26, 1003-1010.
|
|
[47]
|
McCarty, M.F. (2012) Metformin May Antagonize Lin28 and/or Lin28B Activity, Thereby Boosting Let-7 Levels and Antagonizing Cancer Progression. Medical Hypotheses, 78, 262-269.
http://dx.doi.org/10.1016/j.mehy.2011.10.041
|
|
[48]
|
Li, Y., VandenBoom, T.G., Kong, D., et al. (2009) Up-Regulation of miR-200 and Let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells. Cancer Research, 69, 6704-6712. http://dx.doi.org/10.1158/0008-5472.CAN-09-1298
|
|
[49]
|
Li, J., Zhang, Y., Zhao, J., et al. (2011) Over Expression of miR-22 Reverses Paclitaxel-Induced Chemoresistance through Activation of PTEN Signaling in p53-Mutated Colon Cancer Cells. Molecular and Cellular Biochemistry, 357, 31-38. http://dx.doi.org/10.1007/s11010-011-0872-8
|
|
[50]
|
Tsuchiya, N., Izumiya, M., Ogata-Kawata, H., et al. (2011) Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-Transcriptional Regulation of p21. Cancer Research, 71, 4628-4639.
http://dx.doi.org/10.1158/0008-5472.CAN-10-2475
|
|
[51]
|
Li, J., Liang, S., Yu, H., et al. (2010) An Inhibitory Effect of miR-22 on Cell Migration and Invasion in Ovarian Cancer. Gynecology Oncology, 119, 543-548. http://dx.doi.org/10.1016/j.ygyno.2010.08.034
|
|
[52]
|
Zhang, J., Yang, Y., Yang, T., et al. (2010) MicroRNA-22, Downregulated in Hepatocellular Carcinoma and Correlated with Prognosis, Suppresses Cell Proliferation and Tumourigenicity. British Journal of Cancer, 103, 1215-1220.
http://dx.doi.org/10.1038/sj.bjc.6605895
|
|
[53]
|
Brabletz, S. and Brabletz, T. (2010) The ZEB/miR-200 Feedback Loop—A Motor of Cellular Plasticity in Development and Cancer? EMBO Reports, 11, 670-677. http://dx.doi.org/10.1038/embor.2010.117
|
|
[54]
|
Zhang, Z., Liu, X., Feng, B., et al. (2014) STIM1, a Direct Target of MicroRNA-185, Promotes Tumor Metastasis and Is Associated with Poor Prognosis in Colorectal Cancer. Oncogene, in press.
|
|
[55]
|
Lutgendorf, S.K., DeGeest, K., Dahmoush, L., et al. (2011) Social Isolation Is Associated with Elevated Tumor Norepinephrine in Ovarian Carcinoma Patients. Brain, Behavior, and Immunity, 25, 250-255.
http://dx.doi.org/10.1016/j.bbi.2010.10.012
|
|
[56]
|
Thaker, P.H., Han, L.Y., Kamat, A.A., et al. (2006) Chronic Stress Promotes Tumor Growth and Angiogenesis in a Mouse Model of Ovarian Carcinoma. Nature Medicines, 12, 939-944.
http://dx.doi.org/10.1038/nm1447
|
|
[57]
|
Schuller, H.M., Al-Wadei, H.A., Ullah, M.F. and Plummer, H.K. (2012) Regulation of Pancreatic Cancer by Neuropsychological Stress Responses: A Novel Target for Intervention. Carcinogenesis, 33, 191-196.
http://dx.doi.org/10.1093/carcin/bgr251
|
|
[58]
|
Sastry, K.S., Karpova, Y., Prokopovich, S., et al. (2007) Epinephrine Protects Cancer Cells from Apoptosis via Activation of cAMP-Dependent Protein Kinase and BAD Phosphorylation. The Journal of Biological Chemistry, 282, 14094-14100. http://dx.doi.org/10.1074/jbc.M611370200
|
|
[59]
|
Hassan, S., Karpova, Y., Baiz, D., et al. (2013) Behavioral Stress Accelerates Prostate Cancer Development in Mice. The Journal of Clinical Investigation, 123, 874-886.
|
|
[60]
|
Wu, W.K., Wong, H.P., Luo, S.W., et al. (2005) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone from Cigarette Smoke Stimulates Colon Cancer Growth via β-Adrenoceptors. Cancer Research, 65, 5272-5277.
http://dx.doi.org/10.1158/0008-5472.CAN-05-0205
|
|
[61]
|
Wong, H.P., Ho, J.W., Koo, M.W., et al. (2011) Effects of Adrenaline in Human Colon Adenocarcinoma HT-29 Cells. Life Science, 88, 1108-1112. http://dx.doi.org/10.1016/j.lfs.2011.04.007
|
|
[62]
|
Lee, J.W., Shahzad, M.M., Lin, Y.G., et al. (2009) Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma. Clinical Cancer Research, 15, 2695-2702. http://dx.doi.org/10.1158/1078-0432.CCR-08-2966
|
|
[63]
|
Yang, E., Boire, A., Agarwal, A., et al. (2009) Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis. Cancer Research, 69, 6223-6231. http://dx.doi.org/10.1158/0008-5472.CAN-09-0187
|
|
[64]
|
Yang, E.V., Kim, S.J., Donovan, E.L., et al. (2009) Norepinephrine Upregulates VEGF, IL-8, and IL-6 Expression in Human Melanoma Tumor Cell Lines: Implications for Stress-Related Enhancement of Tumor Progression. Brain, Behavior, and Immunity, 23, 267-275. http://dx.doi.org/10.1016/j.bbi.2008.10.005
|
|
[65]
|
Madden, K.S., Szpunar, M.J., Brown, E.B. (2011) β-Adrenergic Receptors (β-AR) Regulate VEGF and IL-6 Production by Divergent Pathways in High β-AR-Expressing Breast Cancer Cell Lines. Breast Cancer Research and Treatment, 130, 747-758. http://dx.doi.org/10.1007/s10549-011-1348-y
|
|
[66]
|
Casini, G., Dal Monte, M., Fornaciari, I., et al. (2014) The β-Adrenergic System as a Possible New Target for Pharmacologic Treatment of Neovascular Retinal Diseases. Progress in Retinal and Eye Research, 42, 103-129
|
|
[67]
|
Ciccarelli, M., Sorriento, D., Cipolletta, E., et al. (2011) Impaired Neoangiogenesis in β(2)-Adrenoceptor Gene-Deficient Mice: Restoration by Intravascular Human β(2)-Adrenoceptor Gene Transfer and Role of NFkappaB and CREB Transcription Factors. British Journal of Pharmacology, 162, 712-721.
http://dx.doi.org/10.1111/j.1476-5381.2010.01078.x
|
|
[68]
|
Ciccarelli, M., Santulli, G., Campanile, A., et al. (2008) Endothelial α1-Adrenoceptors Regulate Neo-Angiogenesis. British Journal of Pharmacology, 153, 936-946. http://dx.doi.org/10.1038/sj.bjp.0707637
|
|
[69]
|
Sorriento, D., Santulli, G., Del Giudice, C., et al. (2012) Endothelial Cells Are Able to Synthesize and Release Catecholamines Both in Vitro and in Vivo. Hypertension, 60, 129-136.
http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.189605
|
|
[70]
|
Vroon, A., Heijnen, C.J. and Kavelaars, A. (2006) GRKs and Arrestins: Regulators of Migration and Inflammation. Journal of Leukocyte Biology, 80, 1214-1221. http://dx.doi.org/10.1189/jlb.0606373
|
|
[71]
|
Reiter, E. and Lefkowitz, R.J. (2006) GRKs and β-Arrestins: Roles in Receptor Silencing, Trafficking and Signaling. Trends in Endocrinology and Metabolism, 17, 159-165.
http://dx.doi.org/10.1016/j.tem.2006.03.008
|
|
[72]
|
Pitcher, J.A., Freedman, N.J. and Lefkowitz, R.J. (1998) G Protein-Coupled Receptor Kinases. Annual Review of Biochemistry, 67, 653-692. http://dx.doi.org/10.1146/annurev.biochem.67.1.653
|
|
[73]
|
Koch, W.J., Ingles, J., Stone, W.C. and Lefkowitz, R.J. (1993) The Binding Site for the Beta Gamma Subunits of Heterotrimeric G Proteins on the Beta-Adrenergic Receptor Kinase. The Journal of Biological Chemistry, 268, 8256-8260.
|
|
[74]
|
Luttrell, L.M., van Biesen, T., Hawes, B.E., et al. (1995) Gβγ Subunits Mediate Mitogen-Activated Protein Kinase Activation by the Tyrosine Kinase Insulin-Like Growth Factor 1 Receptor. The Journal of Biological Chemistry, 270, 16495-16498. http://dx.doi.org/10.1074/jbc.270.28.16495
|
|
[75]
|
Eichmann, T., Lorenz, K., Hoffmann, M., et al. (2003) The Amino-Terminal Domain of G-Protein-Coupled Receptor Kinase 2 Is a Regulatory Gβγ Binding Site. The Journal of Biological Chemistry, 278, 8052-8057.
http://dx.doi.org/10.1074/jbc.M204795200
|
|
[76]
|
Premont, R.T., Macrae, A.D., Stoffel, R.H., et al. (1996) Characterization of the G Protein-Coupled Receptor Kinase GRK4. Identification of Four Splice Variants. The Journal of Biological Chemistry, 271, 6403-6410.
http://dx.doi.org/10.1074/jbc.271.11.6403
|
|
[77]
|
Premont, R.T., Koch, W.J., Inglese, J. and Lefkowitz, R.J. (1994) Identification, Purification, and Characterization of GRK5, a Member of the Family of G Protein-Coupled Receptor Kinases. The Journal of Biological Chemistry, 269, 6832-6841.
|
|
[78]
|
Stoffel, R.H., Randall, R.R., Premont, R.T., et al. (1994) Palmitoylation of G Protein-Coupled Receptor Kinase, GRK6. Lipid Modification Diversity in the GRK Family. The Journal of Biological Chemistry, 269, 27791-27794.
|
|
[79]
|
Penela, P., Murga, C., Ribas, C., et al. (2010) The Complex G Protein-Coupled Receptor Kinase 2 (GRK2) Interactome Unveils New Physiopathological Targets. The Journal of Biological Chemistry, 160, 821-832.
http://dx.doi.org/10.1111/j.1476-5381.2010.00727.x
|
|
[80]
|
Ciccarelli, M., Chuprun, J.K., Rengo, G., et al. (2011) G protein-Coupled Receptor Kinase 2 Activity Impairs Cardiac Glucose Uptake and Promotes Insulin Resistance after Myocardial Ischemia. Circulation, 123, 1953-1962.
http://dx.doi.org/10.1161/CIRCULATIONAHA.110.988642
|
|
[81]
|
Penela, P., Rivas, V., Salcedo, A. and Mayor Jr., F. (2010) G Protein-Coupled Receptor Kinase 2 (GRK2) Modulation and Cell Cycle Progression. Proceedings of the National Academy of Sciences of the United States of America, 107, 1118-1123. http://dx.doi.org/10.1073/pnas.0905778107
|
|
[82]
|
Iaccarino, G., Ciccarelli, M., Sorriento, D., et al. (2005) Ischemic Neoangiogenesis Enhanced by β2-Adrenergic Receptor over Expression: A Novel Role for the Endothelial Adrenergic System. Circulation Research, 97, 1182-1189.
http://dx.doi.org/10.1161/01.RES.0000191541.06788.bb
|
|
[83]
|
Penela, P., Nogues, L. and Mayor Jr., F. (2014) Role of G Protein-Coupled Receptor Kinases in Cell Migration. Current Opinion in Cell Biology, 27, 10-17. http://dx.doi.org/10.1016/j.ceb.2013.10.005
|
|
[84]
|
Clift, I.C., Bamidele, A.O., Rodriguez-Ramirez, C., et al. (2014) β-Arrestin1 and Distinct CXCR4 Structures Are Required for Stromal Derived Factor-1 to Downregulate CXCR4 Cell-Surface Levels in Neuroblastoma. Molecular Pharmacology, 85, 542-552. http://dx.doi.org/10.1124/mol.113.089714
|
|
[85]
|
Jiang, X., Yang, P. and Ma, L. (2009) Kinase Activity-Independent Regulation of Cyclin Pathway by GRK2 Is Essential for Zebrafish Early Development. Proceedings of the National Academy of Sciences of the United States of America, 106, 10183-10188. http://dx.doi.org/10.1073/pnas.0812105106
|
|
[86]
|
Ciccarelli, M., Sorriento, D., Franco, A., et al. (2013) Endothelial G Protein-Coupled Receptor Kinase 2 Regulates Vascular Homeostasis through the Control of Free Radical Oxygen Species. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 2415-2424. http://dx.doi.org/10.1161/ATVBAHA.113.302262
|
|
[87]
|
Rivas, V., Carmona, R., Munoz-Chapuli, R., et al. (2013) Developmental and Tumoral Vascularization Is Regulated by G Protein-Coupled Receptor Kinase 2. The Journal of Clinical Investigation, 123, 4714-4730.
http://dx.doi.org/10.1172/JCI67333
|
|
[88]
|
Sorriento, D., Santulli, G., Fusco, A., et al. (2010) Intracardiac Injection of AdGRK5-NT Reduces Left Ventricular Hypertrophy by Inhibiting NF-κB-Dependent Hypertrophic Gene Expression. Hypertension, 56, 696-704.
http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.155960
|
|
[89]
|
Sorriento, D., Campanile, A., Santulli, G., et al. (2009) A New Synthetic Protein, TAT-RH, Inhibits Tumor Growth through the Regulation of NFkappaB Activity. Molecular Cancer, 8, 97.
http://dx.doi.org/10.1186/1476-4598-8-97
|
|
[90]
|
Chakraborty, P.K., Zhang, Y., Coomes, A.S., et al. (2014) G Protein-Coupled Receptor Kinase GRK5 Phosphorylates Moesin and Regulates Metastasis in Prostate Cancer. Cancer Research, 74, 3489-3500.
http://dx.doi.org/10.1158/0008-5472.CAN-13-2708
|
|
[91]
|
Buss, M.C., Remke, M., Lee, J., et al. (2014) The WIP1 Oncogene Promotes Progression and Invasion of Aggressive Medulloblastoma Variants. Oncogene, in press.
|
|
[92]
|
Michal, A.M., So, C.H., Beeharry, N., et al. (2012) G Protein-Coupled Receptor Kinase 5 Is Localized to Centrosomes and Regulates Cell Cycle Progression. The Journal of Biological Chemistry, 287, 6928-6940.
http://dx.doi.org/10.1074/jbc.M111.298034
|
|
[93]
|
Chen, X., Zhu, H., Yuan, M., et al. (2010) G-Protein-Coupled Receptor Kinase 5 Phosphorylates p53 and Inhibits DNA Damage-Induced Apoptosis. The Journal of Biological Chemistry, 285, 12823-12830.
http://dx.doi.org/10.1074/jbc.M109.094243
|
|
[94]
|
Li, Y.P. (2013) GRK6 Expression in Patients with Hepatocellular Carcinoma. Asian Pacific Journal of Tropical Medicine, 6, 220-223. http://dx.doi.org/10.1016/S1995-7645(13)60027-9
|
|
[95]
|
Yuan, L., Zhang, H., Liu, J., et al. (2013) Growth factor receptor-Src-Mediated Suppression of GRK6 Dysregulates CXCR4 Signaling and Promotes Medulloblastoma Migration. Molecular Cancer, 12, 18.
http://dx.doi.org/10.1186/1476-4598-12-18
|
|
[96]
|
Raghuwanshi, S.K., Smith, N., Rivers, E.J., et al. (2013) G Protein-Coupled Receptor Kinase 6 Deficiency Promotes Angiogenesis, Tumor Progression, and Metastasis. The Journal of Immunology, 190, 5329-5336.
http://dx.doi.org/10.4049/jimmunol.1202058
|
|
[97]
|
Raghuwanshi, S.K., Su, Y., Singh, V., et al. (2012) The Chemokine Receptors CXCR1 and CXCR2 Couple to Distinct G Protein-Coupled Receptor Kinases to Mediate and Regulate Leukocyte Functions. The Journal of Immunology, 189, 2824-2832. http://dx.doi.org/10.4049/jimmunol.1201114
|
|
[98]
|
Hook, S.S. and Means, A.R. (2001) Ca2+/CaM-Dependent Kinases: From Activation to Function. Annual Review of Pharmacology and Toxicology, 41, 471-505.
http://dx.doi.org/10.1146/annurev.pharmtox.41.1.471
|
|
[99]
|
Cruzalegui, F.H. and Bading, H. (2000) Calcium-Regulated Protein Kinase Cascades and Their Transcription Factor Targets. Cellular and Molecular Life Sciences CMLS, 57, 402-410.
http://dx.doi.org/10.1007/PL00000702
|
|
[100]
|
Wang, S.L., Ribar, T.J. and Means, A.R. (2001) Expression of Ca2+/Calmodulin-Dependent Protein Kinase IV (caMKIV) Messenger RNA during Murine Embryogenesis. Cell Growth & Differentiation, 12, 351-361.
|
|
[101]
|
Kitsos, C.M., Sankar, U., Illario, M., et al. (2005) Calmodulin-Dependent Protein Kinase IV Regulates Hematopoietic Stem Cell Maintenance. The Journal of Biological Chemistry, 280, 33101-33108.
http://dx.doi.org/10.1074/jbc.M505208200
|
|
[102]
|
Kim Do, Y., Park, M.W., Yuan, H.D., et al. (2009) Compound K Induces Apoptosis via CAMK-IV/AMPK Pathways in HT-29 Colon Cancer Cells. Journal of Agricultural and Food Chemistry, 57, 10573-10578.
http://dx.doi.org/10.1021/jf902700h
|
|
[103]
|
Tamura, N., Tai, Y., Sugimoto, K., et al. (2000) Enhanced Expression and Activation of Ca2+/Calmodulin-Dependent Protein Kinase IV in Hepatocellular Carcinoma. Cancer, 89, 1910-1916.
http://dx.doi.org/10.1002/1097-0142(20001101)89:9<1910::AID-CNCR6>3.3.CO;2-M
|
|
[104]
|
Shang, S., Takai, N., Nishida, M., et al. (2003) CaMKIV Expression Is Associated with Clinical Stage and PCNA-Labeling Index in Endometrial Carcinoma. International Journal of Molecular Medicine, 11, 181-186.
|
|
[105]
|
Takai, N., Miyazaki, T., Nishida, M., et al. (2002) Ca2+/Calmodulin-Dependent Protein Kinase IV Expression in Epithelial Ovarian Cancer. Cancer Letters, 183, 185-193. http://dx.doi.org/10.1016/S0304-3835(02)00107-6
|
|
[106]
|
Braun, A.P. and Schulman, H. (1995) The Multifunctional Calcium/Calmodulin-Dependent Protein Kinase: From Form to Function. Annual Review of Physiology, 57, 417-445.
http://dx.doi.org/10.1146/annurev.ph.57.030195.002221
|
|
[107]
|
Yang, B.F., Xiao, C., Roa, W.H., et al. (2003) Calcium/Calmodulin-Dependent Protein Kinase II Regulation of c-FLIP Expression and Phosphorylation in Modulation of Fas-Mediated Signaling in Malignant Glioma Cells. The Journal of Biological Chemistry, 278, 7043-7050. http://dx.doi.org/10.1074/jbc.M211278200
|
|
[108]
|
Xiao, C., Yang, B.F., Song, J.H., et al. (2005) Inhibition of CaMKII-Mediated c-FLIP Expression Sensitizes Malignant Melanoma Cells to TRAIL-Induced Apoptosis. Experimental Cell Research, 304, 244-255.
http://dx.doi.org/10.1016/j.yexcr.2004.11.002
|
|
[109]
|
Rodriguez-Mora, O.G., Lahair, M.M., Evans, M.J., et al. (2006) Inhibition of the CaM-Kinases Augments Cell Death in Response to Oxygen Radicals and Oxygen Radical Inducing Cancer Therapies in MCF-7 Human Breast Cancer Cells. Cancer Biology & Therapy, 5, 1022-1030. http://dx.doi.org/10.4161/cbt.5.8.2910
|
|
[110]
|
Tombes, R.M. and Krystal, G.W. (1997) Identification of Novel Human Tumor Cell-Specific CaMK-II Variants. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1355, 281-292.
http://dx.doi.org/10.1016/S0167-4889(96)00141-3
|
|
[111]
|
Song, J.H., Bellail, A., Tse, M.C.L., Yong, V.W. and Hao, C.H. (2006) Human Astrocytes Are Resistant to Fas Ligand and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis. The Journal of Neuroscience, 26, 3299-3308.
http://dx.doi.org/10.1523/JNEUROSCI.5572-05.2006
|
|
[112]
|
Fladmark, K.E., Brustugun, O.T., Mellgren, G., et al. (2002) Ca2+/Calmodulin-Dependent Protein Kinase II Is Required for Microcystin-Induced Apoptosis. The Journal of Biological Chemistry, 277, 2804-2811.
http://dx.doi.org/10.1074/jbc.M109049200
|
|
[113]
|
Daft, P.G., Yuan, K., Warram, J.M., et al. (2013) Alpha-CaMKII Plays a Critical Role in Determining the Aggressive Behavior of Human Osteosarcoma. Molecular Cancer Research, 11, 349-359.
http://dx.doi.org/10.1158/1541-7786.MCR-12-0572
|
|
[114]
|
Wang, Q., Symes, A.J., Kane, C.A., et al. (2010) A Novel Role for Wnt/Ca2+ Signaling in Actin Cytoskeleton Remodeling and Cell Motility in Prostate Cancer. PLoS ONE, 5, e10456.
http://dx.doi.org/10.1371/journal.pone.0010456
|
|
[115]
|
Rokhlin, O.W., Taghiyev, A.F., Bayer, K.U., et al. (200) Calcium/Calmodulin-Dependent Kinase II Plays an Important Role in Prostate Cancer Cell Survival. Cancer Biology & Therapy, 6, 732-742.
http://dx.doi.org/10.4161/cbt.6.5.3975
|
|
[116]
|
Liu, Z., Han, G., Cao, Y., et al. (2014) Calcium/Calmodulin-Dependent Protein Kinase II Enhances Metastasis of Human Gastric Cancer by Upregulating Nuclear Factor-κB and Akt-Mediated Matrix Metalloproteinase-9 Production. Molecular Medicine Reports, 10, 2459-2464.
|
|
[117]
|
Rusciano, M.R., Salzano, M., Monaco, S., et al. (2010) The Ca2+-Calmodulin-Dependent Kinase II Is Activated in Papillary Thyroid Carcinoma (PTC) and Mediates Cell Proliferation Stimulated by RET/PTC. Endocrine-Related Cancer, 17, 113-123. http://dx.doi.org/10.1677/ERC-09-0214
|
|
[118]
|
Si, J., Mueller, L. and Collins, S.J. (2007) CaMKII Regulates Retinoic Acid Receptor Transcriptional Activity and the Differentiation of Myeloid Leukemia Cells. The Journal of Clinical Investigation, 117, 1412-1421.
http://dx.doi.org/10.1172/JCI30779
|
|
[119]
|
Gu, Y., Chen, T., Meng, Z., et al. (2012) CaMKII gamma, a Critical Regulator of CML stem/Progenitor Cells, Is a Target of the Natural Product Berbamine. Blood Journal, 120, 4829-4839.
http://dx.doi.org/10.1182/blood-2012-06-434894
|
|
[120]
|
Monaco, S., Rusciano, M.R., Maione, A.S., et al. (2015) A Novel Crosstalk between Calcium/Calmodulin Kinases II and IV Regulates Cell Proliferation in Myeloid Leukemia Cells. Cell Signalling, 27, 204-214.
http://dx.doi.org/10.1016/j.cellsig.2014.11.007
|
|
[121]
|
Ciccarelli, M., Rusciano, M.R., Sorriento, D., et al. (2014) CaMKII Protects MKP-1 from Proteasome Degradation in Endothelial Cells. Cellular Signalling, 26, 2167-2174.
http://dx.doi.org/10.1016/j.cellsig.2014.06.009
|